Rev Med UAS
Vol. 13: No. 2. Abril-Junio 2023
ISSN 2007-8013

Impacto materno y perinatal de la infección de vías urinarias en el embarazo: una revisión

Maternal and perinatal impact of urinary tract infection in pregnancy: a review

Ana Karen Jacobo-Gallardo1, Josefina Báez-Barraza2, Everardo Quevedo-Castro1, Fred Morgan-Ruiz1, Guadalupe López-Manjarrez3, Perla Yareli Gutiérrez-Arzapalo4, Fred Morgan-Ortiz4

  1. Departamento de Ginecología y Obstetricia del Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México
  2. Ginecología y Obstetricia, Hospital Ángeles Culiacán,
  3. Profesor e Investigador de Tiempo Completo, Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México.
  4. Departamento de Investigación del Centro de Investigación y Docencia en Ciencias de la Salud en el Hospital Civil de Culiacán de la Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, México.

*Autor de correspondencia: Dra. Ana Karen Jacobo-Gallardo
Eustaquio Buelna No. 91, Col. Gabriel Leyva, Culiacán, Sinaloa México. CP: 80030.
Tel, 6677132606; Correo electrónico: anakarenjaga@gmail.com

DOI http://dx.doi.org/10.28960/revmeduas.2007-8013.v13.n2.010

Texto Completo PDF

Recibido: 27 de febrero 2022, aceptado 08 septiembre de 2022

RESUMEN
La segunda patología más frecuente encontrada en la mujer embarazada son las infecciones del tracto urinario, suponiendo un gran reto terapéutico dado al compromiso materno y fetal que pueden ocasionar. Durante el embarazo existen cambios funcionales, estructurales y fisiológicos del tracto urinario, dichos cambios promueven la invasión de los gérmenes desde la uretra y el desarrollo de la patología urinaria. Por lo anterior mencionado, toda la mujer embarazada debe someterse a un cribado de bacteriuria asintomática mediante urocultivo, y en caso de ser positivo, siempre recibir tratamiento antimicrobiano, pues es un factor de riesgo importante para el desarrollo de Pielonefritis durante el embarazo, a diferencia de la mujer no gestante.
Palabras clave: Infección urinaria, Bacteriuria asintomática, Embarazo, Cistitis, Pielonefritis aguda.

ABSTRACT
The second most frequent pathology found in pregnant women is urinary tract infections, posing a great therapeutic challenge due to the maternal and fetal compromise that they can cause. During pregnancy there are functional, structural and physiological changes of the urinary tract, these changes promote the invasion of germs from the urethra and the development of urinary pathology. Therefore, all pregnant women should undergo asymptomatic bacteriuria screening by urine culture, and if positive, always receive antimicrobial treatment, as it is an important risk factor for the development of Pyelonephritis during pregnancy, unlike of the non-pregnant woman.
Keywords: Urinary infection, Asymptomatic bacteriuria, Pregnancy, Cystitis, Acute pyelonephritis

Referencias

  1. Sánchez GC. Valor Predictivo del Urocultivo en el diagnóstico de las complicaciones obstétricas y neonatales, en gestantes adolescentes y añosas atendidas en el INMP, durante el 2011. HorizMed 2013; 13 ():122–135.
  2. Martínez E, Osorio J, Delgado J, Esparza G. Infecciones del tracto urinario bajo en adultos y embarazadas: consenso para el manejo empírico. Infection. 2013;17(3):122–135.
  3. Vallejos C, López M, Enríquez M. Prevalencia de infecciones de vías urinarias en embarazadas atendidas en el Hospital Universitario de Puebla. Enf Inf Microbiol 2010 30 (4): 118-12.
  4. Szweda H, Jóźwik M. Urinary tract infections during pregnancy – an updated overview. Dev Period Med. 2016;20(4):263-272.
  5. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2019(11)
  6. Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38 Suppl 2:50-57
  7. Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014;210(3)
  8. Angelescu K, Nussbaumer B, Sieben W, Scheibler F, Gartlehner G. Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC Pregnancy Childbirth. 2016; 16(1):336.
  9. Kazemier BM, Koningstein FN, Schneeberger C. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet In fect Dis. 2015; 15(11):1324-1333.
  10. Acosta TJ, Ramos MA, Zamora AL, Murillo L. Prevalence of urinary tract infection in hospitalized patients with preterm labor. Ginecol Obstet Mex. 2014 Nov; 82(11):737-43.
  11. Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59(RR-10):1-36.
  12. Newton E. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol. 2005; 32(3):571-600.
  13. Hill JB, Sheffield JS, McIntire DD, Wendel GD. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005; 105(1):18-23.
  14. Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014 Mar;210(3):219.e1-6
  15. Teppa RJ, Roberts JM. The Uriscreen Test to detect signicant asymptomatic bacteriuria during pregnancy. J Soc Gynecol Investig, 2005, 12, 50-53.
  16. Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):1611-1615
  17. Salvatore S, Salvatore S, Cattoni E. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011;156(2):131-136.
  18. Rossi P, Cimerman S, Truzzi JC, Cunha CAD, Mattar R, Martino MD, et al. Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women. Braz J Infect Dis. 2020 Mar-Apr;24(2):110-119.
  19. Widmer M, Lopez I, Gülmezoglu AM, Mignini L, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2015 Nov 11;(11).
  20. Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection. 1992;20 Suppl 4:S313-S316.
  21. Gupta K, Hooton TM, Naber KG. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-e120.
  22. Wing DA. Pyelonephritis in pregnancy: treatment options for optimal outcomes. Drugs. 2001;61(14):2087-2096.
  23. Ennis M, Callaway L, Lust K. Adherence to evidence-based guidelines for the management of pyelonephritis in pregnancy. Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):505-9.
  24. Glaser AP, Schaeffer AJ. Urinary Tract Infection and Bacteriuria in Pregnancy. Urol Clin North Am. 2015;42(4):547-560.
  25. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015 Mar 16;11(1):67-77.